AAAAAA

   
Results: 1-25 | 26-38
Results: 1-25/38

Authors: BJORHEIM J LYSTAD S LINDBLOM A KRESSNER U WESTRING S WAHLBERG S LINDMARK G GAUDERNACK G EKSTROM P ROE J THILLY WG BORRESENDALE AL
Citation: J. Bjorheim et al., MUTATION ANALYSES OF KRAS EXON-1 COMPARING 3 DIFFERENT TECHNIQUES - TEMPORAL TEMPERATURE-GRADIENT ELECTROPHORESIS, CONSTANT DENATURANT CAPILLARY-ELECTROPHORESIS AND ALLELE-SPECIFIC POLYMERASE-CHAIN-REACTION, Mutation research. Fundamental and molecular mechanisms of mutagenesis, 403(1-2), 1998, pp. 103-112

Authors: GJERTSEN MK GAUDERNACK G
Citation: Mk. Gjertsen et G. Gaudernack, MUTATED RAS PEPTIDES AS VACCINES IN IMMUNOTHERAPY OF CANCER, Vox sanguinis, 74, 1998, pp. 489-495

Authors: PETTERSEN RD GAUDERNACK G OLAFSEN MK LIE SO HESTDAL K
Citation: Rd. Pettersen et al., THE TCR-BINDING REGION OF THE HLA-CLASS-I-ALPHA(2) DOMAIN SIGNALS RAPID FAS-INDEPENDENT CELL-DEATH - A DIRECT PATHWAY FOR T-CELL-MEDIATED KILLING OF TARGET-CELLS, The Journal of immunology, 160(9), 1998, pp. 4343-4352

Authors: SAETERDAL I STRATEN PH MYKLEBUST JH KIRKIN AF GJERTSEN MK GAUDERNACK G
Citation: I. Saeterdal et al., GENERATION AND CHARACTERIZATION OF GP100 PEPTIDE-SPECIFIC NK-T CELL CLONES, International journal of cancer, 75(5), 1998, pp. 794-803

Authors: GAUDERNACK G GJERTSEN MK
Citation: G. Gaudernack et Mk. Gjertsen, MUTANT RAS PEPTIDE VACCINES, European journal of cancer, 33, 1997, pp. 1304-1304

Authors: ANDERSEN SN LOVIG T BREIVIK J LUND E GAUDERNACK G MELING GI ROGNUM TO
Citation: Sn. Andersen et al., K-RAS MUTATIONS AND PROGNOSIS IN LARGE-BOWEL CARCINOMAS, Scandinavian journal of gastroenterology, 32(1), 1997, pp. 62-69

Authors: BREIVIK J LOTHE RA MELING GI ROGNUM TO BORRESENDALE AL GAUDERNACK G
Citation: J. Breivik et al., DIFFERENT GENETIC PATHWAYS TO PROXIMAL AND DISTAL COLORECTAL-CANCER INFLUENCED BY SEX-RELATED FACTORS, International journal of cancer, 74(6), 1997, pp. 664-669

Authors: GJERTSEN MK BJORHEIM J SAETERDAL I MYKLEBUST J GAUDERNACK G
Citation: Mk. Gjertsen et al., CYTOTOXIC CD4(-LYMPHOCYTES, GENERATED BY MUTANT P21-RAS (12VAL) PEPTIDE VACCINATION OF A PATIENT, RECOGNIZE 12VAL-DEPENDENT NESTED EPITOPESPRESENT WITHIN THE VACCINE PEPTIDE AND KILL AUTOLOGOUS TUMOR-CELLS CARRYING THIS MUTATION() AND CD8(+) T), International journal of cancer, 72(5), 1997, pp. 784-790

Authors: RASMUSSEN AM HOREJSI V LEVY FO BLOMHOFF HK SMELAND EB BEISKE K MICHAELSEN TE GAUDERNACK G FUNDERUD S
Citation: Am. Rasmussen et al., CDW78 - A DETERMINANT ON A MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II SUBPOPULATION THAT CAN BE INDUCED TO ASSOCIATE WITH THE CYTOSKELETON, European Journal of Immunology, 27(12), 1997, pp. 3206-3213

Authors: GJERSTEN MK SAETERDAL I BEISKE K GAUDERNACK G
Citation: Mk. Gjersten et al., ANTIGEN-PRESENTING FUNCTION OF HUMAN PERITONEUM MESOTHELIAL CELLS ISOLATED FROM A PANCREATIC-CARCINOMA PATIENT AFTER MUTANT RAS PEPTIDE VACCINATION, Cancer immunology and immunotherapy, 43(5), 1996, pp. 262-268

Authors: STEEN R TJONNFJORD GE GAUDERNACK G BRINCH L EGELAND T
Citation: R. Steen et al., DIFFERENCES IN THE DISTRIBUTION OF CD34 EPITOPES ON NORMAL HAEMO-POIETIC PROGENITOR CELLS AND LEUKEMIC BLAST CELLS, Experimental hematology, 24(9), 1996, pp. 83-83

Authors: PETTERSEN RD HESTDAL K LIE SO GAUDERNACK G
Citation: Rd. Pettersen et al., ROLE OF THE TCR BINDING REGION OF THE HLA CLASS-I ALPHA-2 DOMAIN IN REGULATION OF CELL-ADHESION AND PROLIFERATION, The Journal of immunology, 156(4), 1996, pp. 1415-1424

Authors: GJERTSEN MK BAKKA A BREIVIK J SAETERDAL I GEDDEDAHL T STOKKE KT SOLHEIM BG EGGE TS SOREIDE O THORSBY E GAUDERNACK G
Citation: Mk. Gjertsen et al., EX-VIVO RAS PEPTIDE VACCINATION IN PATIENTS WITH ADVANCED PANCREATIC-CANCER - RESULTS OF A PHASE I II STUDY/, International journal of cancer, 65(4), 1996, pp. 450-453

Authors: STEEN R TJONNFJORD GE GAUDERNACK G BRINCH L EGELAND T
Citation: R. Steen et al., DIFFERENCES IN THE DISTRIBUTION OF CD34 EPITOPES ON NORMAL HEMATOPOIETIC PROGENITOR CELLS AND LEUKEMIC BLAST CELLS, British Journal of Haematology, 94(4), 1996, pp. 597-605

Authors: GJERTSEN MK SAETERDAL I THORSBY E GAUDERNACK G
Citation: Mk. Gjertsen et al., CHARACTERIZATION OF IMMUNE-RESPONSES IN PANCREATIC-CARCINOMA PATIENTSAFTER MUTANT P21 RAS PEPTIDE VACCINATION, British Journal of Cancer, 74(11), 1996, pp. 1828-1833

Authors: ANDERSEN SN BREIVIK J LOVIG T MELING GI GAUDERNACK G CLAUSEN OPF SCHJOLBERG A FAUSA O LANGMARK F LUND E ROGNUM TO
Citation: Sn. Andersen et al., K-RAS MUTATIONS AND HLA-DR EXPRESSION IN LARGE-BOWEL ADENOMAS, British Journal of Cancer, 74(1), 1996, pp. 99-108

Authors: DONAHUE RE BYRNE ER THOMAS TE KIRBY MR AGRICOLA BA SELLERS SE GAUDERNACK G KARLSSON S LANSDORP PM
Citation: Re. Donahue et al., TRANSPLANTATION AND GENE-TRANSFER OF THE HUMAN GLUCOCEREBROSIDASE GENE INTO IMMUNOSELECTED PRIMATE CD34(-1(+) CELLS()THY), Blood, 88(11), 1996, pp. 4166-4172

Authors: FOSSUM B OLSEN AC THORSBY E GAUDERNACK G
Citation: B. Fossum et al., CD8(-CELLS FROM A PATIENT WITH COLON-CARCINOMA, SPECIFIC FOR A MUTANTP21-RAS-DERIVED PEPTIDE (GLY(13)-]ASP), ARE CYTOTOXIC TOWARDS A CARCINOMA CELL-LINE HARBORING THE SAME MUTATION() T), Cancer immunology and immunotherapy, 40(3), 1995, pp. 165-172

Authors: OLSEN AC FOSSUM B KIRKIN AF ZEUTHEN J GAUDERNACK G
Citation: Ac. Olsen et al., A HUMAN-MELANOMA CELL-LINE, RECOGNIZED BY BOTH HLA CLASS-I AND CLASS-II RESTRICTED T-CELLS, IS CAPABLE OF INITIATING BOTH PRIMARY AND SECONDARY IMMUNE-RESPONSES, Scandinavian journal of immunology, 41(4), 1995, pp. 357-364

Authors: VIKEN HD PAULSEN G DROVER S MARSHALL WH SOLLID LM GAUDERNACK G THORSBY E
Citation: Hd. Viken et al., INFLUENCE ON ANTIBODY RECOGNITION OF AMINO-ACID SUBSTITUTIONS IN THE CLEFT OF HLA-DQ2 MOLECULES - SUGGESTIVE EVIDENCE OF PEPTIDE-DEPENDENT EPITOPES, Human immunology, 44(2), 1995, pp. 63-69

Authors: VIKEN HD PAULSEN G SOLLID LM LUNDIN KEA TJONNFJORD GE THORSBY E GAUDERNACK G
Citation: Hd. Viken et al., CHARACTERIZATION OF AN HLA-DQ2-SPECIFIC MONOCLONAL-ANTIBODY - INFLUENCE OF AMINO-ACID SUBSTITUTIONS IN DQ-BETA-1(ASTERISK)0202, Human immunology, 42(4), 1995, pp. 319-327

Authors: GJERTSEN MK BAKKA A BREIVIK J SAETERDAL I SOLHEIM BG SOREIDE O THORSBY E GAUDERNACK G
Citation: Mk. Gjertsen et al., VACCINATION WITH MUTANT RAS PEPTIDES AND INDUCTION OF T-CELL RESPONSIVENESS IN PANCREATIC-CARCINOMA PATIENTS CARRYING THE CORRESPONDING RASMUTATION, Lancet, 346(8987), 1995, pp. 1399-1400

Authors: PURI KD FINGER EB GAUDERNACK G SPRINGER TA
Citation: Kd. Puri et al., SIALOMUCIN CD34 IS THE MAJOR L-SELECTIN LIGAND IN HUMAN TONSIL HIGH ENDOTHELIAL VENULES, The Journal of cell biology, 131(1), 1995, pp. 261-270

Authors: VIKEN HD THORSBY E GAUDERNACK G
Citation: Hd. Viken et al., CHARACTERIZATION AND EPITOPE MAPPING OF 4 HLA CLASS-II REACTIVE MOUSEMONOCLONAL-ANTIBODIES USING TRANSFECTED L CELLS AND HUMAN-CELLS TRANSFECTED WITH MUTANTS OF DQB1-ASTERISK-0302, Tissue antigens, 45(4), 1995, pp. 250-257

Authors: PETTERSEN RD HESTDAL K LEE N GERAGHTY DE VALO ET LIE SO GAUDERNACK G
Citation: Rd. Pettersen et al., RG1, A NEW MURINE MONOCLONAL-ANTIBODY RECOGNIZING A SUPERTYPIC DETERMINANT ON HLA-A MOLECULES, Tissue antigens, 45(3), 1995, pp. 203-212
Risultati: 1-25 | 26-38